Levine Alan M 4
4 · Axogen, Inc. · Filed Jun 3, 2021
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Levine Alan M
Director
Transactions
- Exercise/Conversion
Common Stock
2021-06-01+6,173→ 8,764 total - Exercise/Conversion
Restricted Stock Units
2021-06-01−6,173→ 0 total→ Common Stock (6,173 underlying) - Award
Stock Option (right to buy)
2021-06-01+6,030→ 6,030 totalExercise: $19.76Exp: 2031-06-01→ Common Stock (6,030 underlying) - Award
Restricted Stock Units
2021-06-01+3,036→ 3,036 total→ Common Stock (3,036 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F2]This reflects the number of restricted stock units that became vested as of June 1, 2021.
- [F3]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.